Page last updated: 2024-08-16
rolipram and an2728
rolipram has been researched along with an2728 in 2 studies
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Akama, T; Baker, SJ; Freund, Y; Hernandez, V; Kimura, R; Maples, KR; Plattner, JJ; Sanders, V; Zhang, YK; Zhou, H | 1 |
| Akama, T; Baker, SJ; Bu, W; Freund, Y; Hernandez, VS; Hold, KM; Kimura, R; Lu, XS; Plattner, JJ; Sanders, V; Zhang, YK | 1 |
Other Studies
2 other study(ies) available for rolipram and an2728
| Article | Year |
|---|---|
Discovery and structure-activity study of a novel benzoxaborole anti-inflammatory agent (AN2728) for the potential topical treatment of psoriasis and atopic dermatitis.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Dermatitis, Atopic; Dermatologic Agents; Edema; Humans; Mice; Psoriasis; Structure-Activity Relationship; U937 Cells | 2009 |
Design and synthesis of boron-containing PDE4 inhibitors using soft-drug strategy for potential dermatologic anti-inflammatory application.
Topics: Animals; Anti-Inflammatory Agents; Boron; Cyclic Nucleotide Phosphodiesterases, Type 4; Ear; Edema; Humans; Mice; Phosphodiesterase 4 Inhibitors | 2010 |